Wednesday, February 10, 2010, 6:24pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

NeuroMetrix Inc. (NURO)

At 4:59AM SGT: 2.242 USD   0.00 (0.00%)  
 MORE ON NURO 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 NeuroMetrix, Inc. (NGM:NURO) Delayed quote dataEdit
Last Trade:2.242 USD
Trade Time:4:59AM SGT
Change: 0.00 (0.00%)
Prev Close:2.242
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.30
Day's Range:N/A - N/A
52wk Range:1.11 - 3.60
Volume:0
Avg Vol (3m):34,184.1
Market Cap:51.48M
P/E (ttm):N/A
EPS (ttm):-1.135
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add NURO to Portfolio   Download Data

 HEADLINES 
•NeuroMetrix, Inc. Announces Date for 2009 Financial Results Conference Call
Business Wire (Thu, Feb 4)
•NEUROMETRIX, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Jan 1)
•NeuroMetrix Ready for Public Sale
Zacks.com (Mon, Dec 28)
•Neurometrix registers shares, hints at possible hedge fund exit
at bizjournals.com (Tue, Dec 22)
•Court Dismisses NeuroMetrix Lawsuit
Zacks.com (Fri, Dec 18)
•NEUROMETRIX, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Dec 15)
•Federal Court Dismisses Securities Class Action Lawsuit Against NeuroMetrix, Inc.
Business Wire (Tue, Dec 15)
•NEUROMETRIX, INC. Financials
EDGAR Online Financials (Tue, Nov 17)
•NEUROMETRIX, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
•NeuroMetrix, Inc. Earnings Call scheduled for 8:00 am ET today
CCBN (Thu, Nov 5)
•NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
EDGAR Online (Thu, Nov 5)
•NEUROMETRIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Sep 16)
More Headlines for NURO...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.84
EPS Est (in 2 years) (Dec-10) :-0.39
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
NeuroMetrix, Inc., a medical device company, engages in the development and commercialization of products that aid physicians in the assessment, treatment, and repair of peripheral nerve and spinal cord injuries and disorders, and that provide reg...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices